Imcas 2026: Innovation, ethics and new clinical challenges

Ozempic Face, the impact of rapid slimming on the face

The Congress also devoted space to the Ozempic Face phenomenon, a side effect observed in those who use semaglutide and tirzepatide to achieve rapid weight loss. These drugs, which were created to treat type 2 diabetes and obesity, are also increasingly used by overweight people who want to lose weight quickly. Rapid weight loss can result in a less supported face: loss of tone, hollowed-out cheeks, more tired features. Into this scenario comes Thermage FLX by Solta Medical, a non-invasive monopolar radiofrequency treatment that, in a single session and without downtime, firms tissues and redefines the oval. Professor Paolo Giovanni Arca, a specialist in regenerative aesthetic medicine, has used it in Ozempic Face cases, observing a progressive improvement in skin quality. The technology acts in depth by stimulating collagen neosynthesis, with a natural and harmonious lifting effect.

The structural glow that improves skin quality

In the panorama of aesthetic medicine, there is a growing demand for treatments capable of improving the quality of the skin without changing its features. Responding to this demand is babyGLOW™, the new protocol signed Teoxane, designed to restore light and freshness in a natural and progressive way. The new protocol, based on free hyaluronic acid associated with a dermo-complex with amino acids, antioxidants, vitamins and minerals, is designed to improve radiance, hydration and skin quality. Inspired by contouring and highlighting techniques, the treatment involves micro-injections into 8 strategic points of the face to optimise light reflection, soften shadows and gently redefine contours. Results are visible from the very first session, with minimal downtime. The data show high satisfaction: more than 98% of professionals are satisfied, 97% report an improvement in skin quality and 95% of patients report no downtime.

Multidisciplinary approach to women's intimate health

Within the Congress space was also given to women's health with a session entirely dedicated to the menopause, organised in collaboration with the World Society of Cosmetic Gynecology (WSCG). A moment of scientific discussion that focused on Genito-Urinary Syndrome, a condition that is still too underestimated, but which significantly affects the quality of life of millions of women. Dr. Monica Baldessin, a specialist in general surgery with a master's degree in functional gynaecology, presented a lecture entitled 'Ladylift laser, clinical applications', focusing on the recognition of symptoms of Genito-Urinary Syndrome and the personalisation of treatments through the use of new-generation medical devices and carboxytherapy. The MyGyna project was also presented, an initiative of Dr. Baldessin that stands out for its multidisciplinary approach and its desire to provide women with concrete answers to disorders that are often underestimated.

WOMA is born: female leadership in European aesthetic medicine

The Congress was also an opportunity to launch WOMA - WOmen of Medical Aesthetics, a new European network founded by female leaders in the field with the support of Solta Medical, to strengthen the representation of women in aesthetic medicine, dermatology and surgery. The initiative starts from the realisation of a paradox: although women are widely present as patients and professionals, they remain underrepresented in the scientific debate and in decision-making roles. The aim is to reposition aesthetics as a medical discipline oriented towards quality of life, longevity and long-term care by promoting female leadership and scientific dialogue.